Adolescent and young adult oncology patients in France: Heterogeneity in pathways of care

Background In order to evaluate at the population level the impact of the actions developed in France since 2004 to organize the care of adolescents and young adults (AYAs) with cancer, we conducted the present study to provide an unbiased view of the pathway of care of these patients. Methods Using...

Full description

Saved in:
Bibliographic Details
Published inPediatric blood & cancer Vol. 65; no. 9; pp. e27235 - n/a
Main Authors Desandes, Emmanuel, Brugières, Laurence, Molinié, Florence, Defossez, Gautier, Delafosse, Patricia, Jehannin‐Ligier, Karine, Velten, Michel, Trétarre, Brigitte, Amadéo, Brice, Marrer, Emilie, Woronoff, Anne‐Sophie, Ganry, Olivier, Monnereau, Alain, d'Almeida, Tania, Troussard, Xavier, Daubisse‐Marliac, Laetitia, Bara, Simona, Guizard, Anne‐Valérie, Baldi, Isabelle, Launoy, Guy, Clavel, Jacqueline, Lacour, Brigitte
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.09.2018
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background In order to evaluate at the population level the impact of the actions developed in France since 2004 to organize the care of adolescents and young adults (AYAs) with cancer, we conducted the present study to provide an unbiased view of the pathway of care of these patients. Methods Using a population‐based registry, we conducted a review of all cases of cancer diagnosed during 2012 and 2013 in 15‐ to 24‐year‐old patients living in nineteen French administrative areas. Results The median times for diagnosis and treatment of the 993 included AYAs were 9 weeks (3–22) and 1 day (0–20), respectively. Delays in diagnosis were significantly longer in young adults than in adolescents, especially for soft‐tissue sarcomas (48.7 weeks vs. 15.4 weeks, P = 0.04) and bone tumors (21.4 weeks vs. 10.1 weeks, P = 0.04). The first physicians seen by patients were mostly general practitioners (67.4%). Most patients (77.5%) were treated in adult units. Management decisions were taken within the context of a multidisciplinary team (MDT) in 85.3% of cases. MDT meetings that involved both pediatric and adult oncologists were uncommon (15.7% of patients). Twenty‐six percent of patients were included in randomized or nonrandomized clinical studies. The proportion of inclusion was significantly higher in adolescents (39.5%) than in young adults (16.8%). Conclusion In France, pathways of care for AYAs are heterogeneous. It is necessary to organize a national network of expert centers with adequate medical skills and specific psychosocial support and facilities to provide the best possible care for these patients.
Bibliography:Funding information
Grant sponsor: French National League Against Cancer
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1545-5009
1545-5017
DOI:10.1002/pbc.27235